A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease

Parkinsonism Relat Disord. 2023 May:110:105367. doi: 10.1016/j.parkreldis.2023.105367. Epub 2023 Mar 21.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzimidazoles / therapeutic use
  • Cognition Disorders*
  • Cognitive Dysfunction* / drug therapy
  • Cognitive Dysfunction* / etiology
  • Humans
  • Neuropsychological Tests
  • Parkinson Disease* / complications
  • Parkinson Disease* / drug therapy
  • Parkinson Disease* / psychology

Substances

  • candesartan
  • Benzimidazoles